Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability

Cytokine

Volumn 66, Issue 1, 2014, Pages 7-16

  Zouein, Fouad A ^a,b   Duhé, Roy J ^a,b   Arany, Istvan ^a,b   Shirey, Kristin ^a   Hosler, Jonathan P ^a   Liu, Huiling ^b   Saad, Iman ^c   Kurdi, Mazen ^a,c   Booz, George W ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Cell death; Mitochondria; NF B; Reactive oxygen species; Tumor necrosis factor alpha

Indexed keywords

CELL DEATH; MITOCHONDRIA; NFΚB; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR ALPHA;

ANIMALS; CASPASE 3; CELL NUCLEUS; CELL RESPIRATION; CELL SURVIVAL; CYTOCHROMES C; CYTOPROTECTION; EMBRYO, MAMMALIAN; FIBROBLASTS; HUMANS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893418932     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.12.006     Document Type: Article

References (52)

1. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med 2010, 10:369-373.
2. Grivennikov S.I., Karin M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010, 21:11-19.
3. Vendramini-Costa D.B., Carvalho J.E. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012, 18:3831-3852.
4. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009, 9:798-809.
5. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000, 19:2607-2611.
6. Camporeale A., Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?. Front Biosci (Landmark Ed) 2012, 17:2306-2326.
7. Zouein F.A., Kurdi M., Booz G.W. Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart. JAKSTAT 2013, 2:e24352.
8. Szczepanek K., Lesnefsky E.J., Larner A.C. Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol 2012, 22:429-437.
9. Szczepanek K., Chen Q., Larner A.C., Lesnefsky E.J. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 2012, 12:180-189.
10. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
11. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010, 105:771-785.
12. Sarafian T.A., Montes C., Imura T., Qi J., Coppola G., Geschwind D.H., et al. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS One 2010, 5:e9532.
13. Mantel C., Messina-Graham S., Moh A., Cooper S., Hangoc G., Fu X.Y., et al. Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. Blood 2012, 120:2589-2599.
14. Zhou H., Newnum A.B., Martin J.R., Li P., Nelson M.T., Moh A., et al. Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species. Bone 2011, 49:404-411.
15. Esteve J.M., Mompo J., Garcia de la Asuncion J., Sastre J., Asensi M., Boix J., et al. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J 1999, 13:1055-1064.
16. Morgan M.J., Liu Z.G. Reactive oxygen species in TNFα-induced signaling and cell death. Mol Cells 2010, 30:1-12.
17. Costa-Pereira A.P., Tininini S., Strobl B., Alonzi T., Schlaak J.F., Is'harc H., et al. Mutational switch of an IL-6 response to an interferon-γ-like response. Proc Natl Acad Sci USA 2002, 99:8043-8047.
18. Van Herreweghe F., Festjens N., Declercq W., Vandenabeele P. Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci 2010, 67:1567-1579.
19. Kurdi M., Booz G.W. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS. J Cell Physiol 2007, 212:424-431.
20. Arany I., Faisal A., Clark J.S., Vera T., Baliga R., Nagamine Y. P66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury. Am J Physiol Renal Physiol 2010, 298:F1214-F1221.
21. Schägger H., von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991, 199:223-231.
22. Pennica D., Lam V.T., Weber R.F., Kohr W.J., Basa L.J., Spellman M.W., et al. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry 1993, 32:3131-3138.
23. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
24. Lee H., Herrmann A., Deng J.H., Kujawski M., Niu G., Li Z., et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 2009, 15:283-293.
25. Safa A.R. C-FLIP, a master anti-apoptotic regulator. Exp Oncol 2012, 34:176-184.
26. Silke J., Strasser A. The FLIP side of life. Sci Signal 2013, 6:2.
27. Grad J.M., Zeng X.R., Boise L.H. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 2000, 12:543-549.
28. Varfolomeev E., Goncharov T., Fedorova A.V., Dynek J.N., Zobel K., Deshayes K., et al. C-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J Biol Chem 2008, 283:24295-24299.
29. Mosley J.D., Keri R.A. Splice variants of mIAP1 have an enhanced ability to inhibit apoptosis. Biochem Biophys Res Commun 2006, 348:1174-1183.
30. Larsen S., Nielsen J., Hansen C.N., Nielsen L.B., Wibrand F., Stride N., et al. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 2012, 590:3349-3360.
31. Thu V.T., Kim H.K., Long le T., Lee S.R., Hanh T.M., Ko T.H., et al. NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter. Cardiovasc Res 2012, 94:342-350.
32. Kurdi M., Sivakumaran V., Duhé R.J., Aon M.A., Paolocci N., Booz G.W. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes. Int J Biochem Cell Biol 2012, 44:2106-2115.
33. Huang G., Lu H., Hao A., Ng D.C., Ponniah S., Guo K., et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol Cell Biol 2004, 24:8447-8456.
34. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
35. Elschami M., Scherr M., Philippens B., Gerardy-Schahn R. Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells. Eur J Cell Biol 2013, 92:21-29.
36. Poyton R.O., Ball K.A., Castello P.R. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab 2009, 20:332-340.
37. Boengler K., Ungefug E., Heusch G., Schulz R. The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Pharm Des 2013, 19:6890-6895.
38. Lachance C., Goupil S., Leclerc P., Stattic V. A STAT3 inhibitor, affects human spermatozoa through regulation of mitochondrial activity. J Cell Physiol 2013, 228:704-713.
39. Mackenzie G.G., Huang L., Alston N., Ouyang N., Vrankova K., Mattheolabakis G., et al. Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice. PLoS One 2013, 8:e61532.
40. Shulga N., Pastorino J.G. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci 2012, 125:2995-3003.
41. Lee S.B., Kim J.J., Kim T.W., Kim B.S., Lee M.S., Yoo Y.D. Serum deprivation-induced reactive oxygen species production is mediated by Romo1. Apoptosis 2010, 15:204-218.
42. L. Cell Death Differ 2010, 17:1420-1434.
43. Chung Y.M., Lee S.B., Kim H.J., Park S.H., Kim J.J., Chung J.S., et al. Replicative senescence induced by Romo1-derived reactive oxygen species. J Biol Chem 2008, 283:33763-33771.
44. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 2003, 278:36027-36031.
45. Mailloux R.J., Harper M.E. Mitochondrial proticity and ROS signaling: lessons from the uncoupling proteins. Trends Endocrinol Metab 2012, 23:451-458.
46. Sethi G., Ahn K.S., Xia D., Kurie J.M., Aggarwal B.B. Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-κB activation and NF-κB-regulated antiapoptotic gene products. J Immunol 2007, 179:1926-1933.
47. Lu H., Cao X. GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol Biol Cell 2008, 19:1893-1902.
48. Jung J.E., Kim G.S., Narasimhan P., Song Y.S., Chan P.H. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J Neurosci 2009, 29:7003-7014.
49. Leicht M., Marx G., Karbach D., Gekle M., Köhler T., Zimmer H.G. Mechanism of cell death of rat cardiac fibroblasts induced by serum depletion. Mol Cell Biochem 2003, 251:119-126.
50. Aoki M., Morishita R., Matsushita H., Nakano N., Hayashi S., Tomita N., et al. Serum deprivation-induced apoptosis accompanied by up-regulation of p53 and bax in human aortic vascular smooth muscle cells. Heart Vessels Suppl 1997, 12:71-75.
51. L inhibition. PLoS One 2011, 6:e23577.
52. Mughal W., Dhingra R., Kirshenbaum L.A. Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep 2012, 14:540-547.